Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Peters et al. Benchmarking the ACEnano Toolbox for Characterisation of Nanoparticle Size and Concentration by Interlaboratory Comparison. Molecules 2021, 26, 5315.
Peters R, Elbers I, Undas A, Sijtsma E, Briffa S, Carnell-Morris P, Siupa A, Yoon TH, Burr L, Schmid D, Tentschert J, Hachenberger Y, Jungnickel H, Luch A, Meier F, Kocic J, Kim J, Park BC, Hardy B, Johnston C, Jurkschat K, Radnik J, Hodoroaba VD, Lynch I, Valsami-Jones E. Peters R, et al. Among authors: hardy b. Molecules. 2022 Jul 29;27(15):4849. doi: 10.3390/molecules27154849. Molecules. 2022. PMID: 35956999 Free PMC article.
Benchmarking the ACEnano Toolbox for Characterisation of Nanoparticle Size and Concentration by Interlaboratory Comparisons.
Peters R, Elbers I, Undas A, Sijtsma E, Briffa S, Carnell-Morris P, Siupa A, Yoon TH, Burr L, Schmid D, Tentschert J, Hachenberger Y, Jungnickel H, Luch A, Meier F, Kocic J, Kim J, Park BC, Hardy B, Johnston C, Jurkschat K, Radnik J, Hodoroaba VD, Lynch I, Valsami-Jones E. Peters R, et al. Among authors: hardy b. Molecules. 2021 Sep 1;26(17):5315. doi: 10.3390/molecules26175315. Molecules. 2021. PMID: 34500752 Free PMC article.
Advanced tools for the safety assessment of nanomaterials.
Fadeel B, Farcal L, Hardy B, Vázquez-Campos S, Hristozov D, Marcomini A, Lynch I, Valsami-Jones E, Alenius H, Savolainen K. Fadeel B, et al. Among authors: hardy b. Nat Nanotechnol. 2018 Jul;13(7):537-543. doi: 10.1038/s41565-018-0185-0. Epub 2018 Jul 6. Nat Nanotechnol. 2018. PMID: 29980781 Review.
The eNanoMapper database for nanomaterial safety information.
Jeliazkova N, Chomenidis C, Doganis P, Fadeel B, Grafström R, Hardy B, Hastings J, Hegi M, Jeliazkov V, Kochev N, Kohonen P, Munteanu CR, Sarimveis H, Smeets B, Sopasakis P, Tsiliki G, Vorgrimmler D, Willighagen E. Jeliazkova N, et al. Among authors: hardy b. Beilstein J Nanotechnol. 2015 Jul 27;6:1609-34. doi: 10.3762/bjnano.6.165. eCollection 2015. Beilstein J Nanotechnol. 2015. PMID: 26425413 Free PMC article.
Integrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver models.
Oki NO, Farcal L, Abdelaziz A, Florean O, Doktorova TY, Exner T, Kohonen P, Grafström R, Hardy B. Oki NO, et al. Among authors: hardy b. Toxicol In Vitro. 2019 Feb;54:23-32. doi: 10.1016/j.tiv.2018.09.002. Epub 2018 Sep 7. Toxicol In Vitro. 2019. PMID: 30196099 Free article.
Cancer biology, toxicology and alternative methods development go hand-in-hand.
Kohonen P, Ceder R, Smit I, Hongisto V, Myatt G, Hardy B, Spjuth O, Grafström R. Kohonen P, et al. Among authors: hardy b. Basic Clin Pharmacol Toxicol. 2014 Jul;115(1):50-8. doi: 10.1111/bcpt.12257. Epub 2014 May 23. Basic Clin Pharmacol Toxicol. 2014. PMID: 24779563 Free article. Review.
Emerging technologies for food and drug safety.
Slikker W Jr, de Souza Lima TA, Archella D, de Silva JB Junior, Barton-Maclaren T, Bo L, Buvinich D, Chaudhry Q, Chuan P, Deluyker H, Domselaar G, Freitas M, Hardy B, Eichler HG, Hugas M, Lee K, Liao CD, Loo LH, Okuda H, Orisakwe OE, Patri A, Sactitono C, Shi L, Silva P, Sistare F, Thakkar S, Tong W, Valdez ML, Whelan M, Zhao-Wong A. Slikker W Jr, et al. Among authors: hardy b. Regul Toxicol Pharmacol. 2018 Oct;98:115-128. doi: 10.1016/j.yrtph.2018.07.013. Epub 2018 Jul 23. Regul Toxicol Pharmacol. 2018. PMID: 30048704 Free article.
Adverse outcome pathways: opportunities, limitations and open questions.
Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, Limonciel A, Vinken M, Schildknecht S, Waldmann T, Danen E, van Ravenzwaay B, Kamp H, Gardner I, Godoy P, Bois FY, Braeuning A, Reif R, Oesch F, Drasdo D, Höhme S, Schwarz M, Hartung T, Braunbeck T, Beltman J, Vrieling H, Sanz F, Forsby A, Gadaleta D, Fisher C, Kelm J, Fluri D, Ecker G, Zdrazil B, Terron A, Jennings P, van der Burg B, Dooley S, Meijer AH, Willighagen E, Martens M, Evelo C, Mombelli E, Taboureau O, Mantovani A, Hardy B, Koch B, Escher S, van Thriel C, Cadenas C, Kroese D, van de Water B, Hengstler JG. Leist M, et al. Among authors: hardy b. Arch Toxicol. 2017 Nov;91(11):3477-3505. doi: 10.1007/s00204-017-2045-3. Epub 2017 Oct 19. Arch Toxicol. 2017. PMID: 29051992 Review.
402 results